Skip to content

Clinical trials

Autoimmune Diseases trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Country / region: Malaysia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20112
20122
20131
20202
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Viatris Innovation GmbH2
Anthera Pharmaceuticals1
AstraZeneca1
Eli Lilly and Company1
Erasmus Medical Center1
GlaxoSmithKline1
Human Genome Sciences Inc., a GSK Company1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases13
Immune System Diseases7
Lupus Erythematosus, Systemic6
Connective Tissue Diseases3
Glomerulonephritis2
Glomerulonephritis, IGA2
Kidney Diseases2
Nephritis2
Arthritis, Rheumatoid1
Barth Syndrome1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.